Doxorubicin and Dose-Escalated Cyclophosphamide with Granulocyte Colony-Stimulating Factor for the Treatment of Hormone-Resistant Prostate Cancer Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Antineoplastic Combined Chemotherapy Protocols
  • Granulocyte Colony-Stimulating Factor
  • Prostatic Neoplasms

abstract

  • This is a well-tolerated, active regimen for the treatment of HRPC. Toxicity was not different in patients with prior pelvic XRT, although these patients had a lower MTD.

publication date

  • May 1996

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 8622080

Additional Document Info

start page

  • 1617

end page

  • 25

volume

  • 14

number

  • 5